Price $265.96 |
Market Cap
74.98B
|
Sector Health Care |
Div. Growth
40.70%
|
|
P/E
48.5
|
P/B
2.92
|
P/S
3.99
|
Dividend %
1.40%
|
|
P/CF
-
|
P/FCF
591.4
|
Op. Cash Flow
2.1M
|
FCF
0.4
|
|
Op. Margin
11.80%
|
Net Margin
8.10%
|
ROE
6.00%
|
ROI
5.20%
|
|
ROA
2.90%
|
EPS Growth
-16.00%
|
Current Ratio
1.0
|
Debt/Equity
54.90%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Bimi International Medical Inc (BIMI) | $1.57 | - | - | 6.1M | Strong Buy |
| Applied DNA Sciences Inc (APDN) | $1.26 | - | - | 16.7M | Strong Buy |
| Paratek Pharmaceuticals Inc (PRTK) | $2.19 | - | - | 126.6M | Strong Buy |
| PAVmed Inc (PAVM) | $0.34 | - | - | 42.6M | Strong Buy |
| Enzon Pharmaceuticals Inc (ENZN) | $0.14 | - | - | 14.8M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
